SCHEMBL2023504

SCHEMBL2023504

CC(C)(C)OC(=O)N1CCC(O[Si](C)(C)C(C)(C)C)C1C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.40
CHRM2 P08172 1/20 0.36
CHRM1 P11229 1/20 0.36
CHRM3 P20309 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
ALDH1A1 P00352 1/20 0.35
USP2 O75604 1/20 0.35
RECQL P46063 1/20 0.35
EPHX1 P07099 1/20 0.35
HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7327622 1.00 HSD17B10 (0.40) HSD17B10CHRM2CHRM1CHRM3SMN1; SMN2
SCHEMBL6095020 1.00 HSD17B10 (0.40) HSD17B10CHRM2CHRM1CHRM3SMN1; SMN2
SCHEMBL2023499 1.00 HSD17B10 (0.40) HSD17B10CHRM2CHRM1CHRM3SMN1; SMN2
SCHEMBL7327626 1.00 HSD17B10 (0.40) HSD17B10CHRM2CHRM1CHRM3SMN1; SMN2
SCHEMBL13109503 0.89 CHRM2 (0.36) HSD17B10CHRM2CHRM1CHRM3SMN1; SMN2
SCHEMBL24411297 0.87 EPHX1 (0.36) HSD17B10CHRM2CHRM1CHRM3SMN1; SMN2
SCHEMBL5560650 0.87 EPHX1 (0.36) HSD17B10CHRM2CHRM1CHRM3SMN1; SMN2
SCHEMBL2954122 0.87 EPHX1 (0.36) HSD17B10CHRM2CHRM1CHRM3SMN1; SMN2
SCHEMBL29819835 0.87 EPHX1 (0.36) HSD17B10CHRM2CHRM1CHRM3SMN1; SMN2
SCHEMBL22980251 0.87 CHRM2 (0.35) HSD17B10CHRM2CHRM1CHRM3SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018147626-A1 NOVEL HETEROCYCLIC COMPOUND, ITS PREPARATION METHOD, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2018-08-16 WO disclosed
EP-2516433-A1 SUBSTITUTED N-(1H-INDAZOL-4-YL)IMIDAZO[1, 2-A]PYRIDINE-3- CARBOXAMIDE COMPOUNDS AS CFMS INHIBITORS Array Biopharma, Inc. (US) 2012-10-31 EP disclosed
WO-2011079076-A1 SUBSTITUTED N-(1H-INDAZOL-4-YL)IMIDAZO[1, 2-A]PYRIDINE-3- CARBOXAMIDE COMPOUNDS AS CFMS INHIBITORS ARRAY BIOPHARMA INC. (US) 2011-06-30 WO disclosed